Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Johnson

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|January 31, 2003
A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductaseChloé E Atreya, Eric F Johnson, John J Irwin, et al.
Genome Announcements|April 15, 2017
Permanent Draft Genome Sequence of <i>Desulfurococcus amylolyticus</i> Strain Z-533<sup>T</sup>, a Peptide and Starch Degrader Isolated from Thermal Springs in the Kamchatka Peninsula and Kunashir Island, RussiaDwi Susanti, Eric F Johnson, Alla Lapidus, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Bioorganic & Medicinal Chemistry|January 30, 2007
Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/AktGui-Dong Zhu, Jianchun Gong, Viraj B Gandhi, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Molecular Cancer Research : MCR|November 16, 2018
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone MarrowTodd A Hopkins, William B Ainsworth, Paul A Ellis, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|January 31, 2003
A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductaseChloé E Atreya, Eric F Johnson, John J Irwin, et al.
Genome Announcements|April 15, 2017
Permanent Draft Genome Sequence of <i>Desulfurococcus amylolyticus</i> Strain Z-533<sup>T</sup>, a Peptide and Starch Degrader Isolated from Thermal Springs in the Kamchatka Peninsula and Kunashir Island, RussiaDwi Susanti, Eric F Johnson, Alla Lapidus, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Julie Miyashiro, Keith W Woods, Chang H Park, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Bioorganic & Medicinal Chemistry|January 30, 2007
Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/AktGui-Dong Zhu, Jianchun Gong, Viraj B Gandhi, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Aminopyrimidinone cdc7 kinase inhibitorsKeith W Woods, Chunqiu Lai, Julie M Miyashiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Molecular Cancer Research : MCR|November 16, 2018
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone MarrowTodd A Hopkins, William B Ainsworth, Paul A Ellis, et al.
Pageof 13